Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pharmaceutics|March 28, 2026
Oral Rhizoma Coptis Alkaloids Nanoparticle for Treating Diabetes Through Regulating PI3K/Akt PathwaysYuejiao Liu, Mengyuan Zhu, Qiaoqiao Su, et al.Drug Delivery|October 20, 2021
GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapyPengkai Ma, Guijie Wei, Jianhua Chen, et al.International Journal of Pharmaceutics|November 28, 2024
PD-L1 antibody conjugated dihydrotanshinone I-loaded polymeric nanoparticle for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell deathXue Wang, Ziqi Jing, Xiaobin Huang, et al.Drug Delivery|June 28, 2021
Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacyJianhua Chen, Eerdunbagena Ning, Zhijun Wang, et al.Journal of Gastrointestinal Oncology|May 13, 2022
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective studyRuiqing Chen, Ye Li, Ke Song, et al.Journal of Gastrointestinal Oncology|July 15, 2022
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical studyRuiqing Chen, Lingbing Li, Ye Li, et al.International Journal of Pharmaceutics: X|December 1, 2025
Carrier-free multi-components self-delivery nanocomplex for tumor synergistic therapyPengkai Ma, Ziqi Jing, Xue Wang, et al.Drug Delivery|December 29, 2017
Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugatePengkai Ma, Yi Sun, Jianhua Chen, et al.International Journal of Nanomedicine|April 3, 2015
Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumabPengkai Ma, Xuemei Zhang, Ling Ni, et al.The Journal of Pharmacy and Pharmacology|January 6, 2015
Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathyXuemei Zhang, Junhua Wei, Pengkai Ma, et al.Pageof 2